Casirivimab (Synonyms:卡西瑞单抗)
目录号 : KM32790 CAS No. : 2415933-42-3 纯度 : ≥95%
Casirivimab (REGN10933) 是一种人的单克隆抗体,靶向导致 COVID-19 的 SARS-CoV-2 病毒。Casirivimab 对 COVID-19 变种缺乏疗效。Casirivimab 可与 Imdevimab 联合使用,改变了 K18-hACE2 小鼠对 SARS-CoV-2 δ 型变异的肺反应,有效降低病毒载量,改善病症。
规格 价格 是否有货 数量
1mg
In-stock
5mg 询价 In-stock
10mg 询价 In-stock
50mg 询价 In-stock

Other Forms of Rapamycin:

KKL Med 的所有产品和服务仅用于科学研究,不能被用于人体,兽医,我们也不向个人提供产品和服务。
生物活性
Casirivimab (REGN10933) is a human monoclonal antibody that targets the SARS-CoV-2 virus, which causes COVID-19. Casirivimab is ineffective against COVID-19 variants. Casirivimab can be used in combination with Imdevimab , which alters the lung response of K18-hACE2 mice to the SARS-CoV-2 δ variant, effectively reducing viral load and improving symptoms.
分子量
145.24 kDa
CAS号
2415933-42-3
中文名称
Casirivimab
运输条件
Shipping with dry ice.
储存方式
Store at -20˚C 
暂无相关参考文献
The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2